Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - AOXING PHARMACEUTICAL COMPANY, INC.Financial_Report.xls
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. - AOXING PHARMACEUTICAL COMPANY, INC.aoxingexh312.htm
EX-21.1 - LIST OF SUBSIDIARIES - AOXING PHARMACEUTICAL COMPANY, INC.aoxingexh21.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. - AOXING PHARMACEUTICAL COMPANY, INC.aoxingexh311.htm
EX-32.1 - CERTIFICATE OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.SS.1350. - AOXING PHARMACEUTICAL COMPANY, INC.aoxingexh321.htm
10-K - AOXING PHARMACEUTICAL COMPANY, INC. 10K 2014-06-30 - AOXING PHARMACEUTICAL COMPANY, INC.aoxing.htm
Exhibit 32.2


  CERTIFICATION OF CHIEF EXECUTIVE OFFICER
 
PURSUANT TO 18 U.S.C. §1350
 
 
Pursuant to 18 U.S.C. §1350 and in connection with the Annual Report on Form 10-K of Aoxing Pharmaceutical Company, Inc. (the “Company”) for the fiscal year ended June 30, 2014 (the “Report”), I, Guoan Zhang, Chief Financial Officer of the Company, hereby certify that to the best of my knowledge and belief:
 
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period.
 

 
/s/ Guoan Zhang
 
Guoan Zhang, Acting Chief Financial Officer
 
 
Date: September 29, 2014
 
A signed original of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request